| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
1,245 |
1,141 |
$96K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
3,630 |
3,096 |
$77K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,626 |
4,433 |
$35K |
| J9035 |
Injection, bevacizumab, 10 mg |
1,838 |
1,588 |
$9K |
| 92134 |
|
4,874 |
4,708 |
$9K |
| 92250 |
|
1,910 |
1,890 |
$8K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
804 |
796 |
$5K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
12 |
12 |
$4K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
662 |
662 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
889 |
869 |
$1K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
131 |
131 |
$822.33 |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
208 |
208 |
$585.81 |
| 2022F |
|
55 |
46 |
$347.70 |
| 67228 |
|
13 |
13 |
$14.47 |
| 99024 |
|
35 |
26 |
$0.00 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
45 |
38 |
$0.00 |